Results 91 to 100 of about 1,993,187 (364)

Medication Use in Multiple Sclerosis: A Population‐Based Comparison With the General Danish Population

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To investigate the overall use of prescription medications among individuals with multiple sclerosis compared to the general population, with a focus on treatments beyond disease‐modifying therapies. Methods We conducted a nationwide, registry‐based study in Denmark.
Josefine Windfeld‐Mathiasen   +4 more
wiley   +1 more source

Fatigue crack propagation in microcapsule toughened epoxy [PDF]

open access: yes, 2004
The addition of liquid-filled urea-formaldehyde (UF) microcapsules to an epoxy matrix leads to significant reduction in fatigue crack growth rate and corresponding increase in fatigue life.
Brown, Eric N.   +2 more
core   +1 more source

ICU‐EEG Pattern Detection by a Convolutional Neural Network

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Patients in the intensive care unit (ICU) often require continuous EEG (cEEG) monitoring due to the high risk of seizures and rhythmic and periodic patterns (RPPs). However, interpreting cEEG in real time is resource‐intensive and heavily relies on specialized expertise, which is not always available.
Giulio Degano   +5 more
wiley   +1 more source

Estimation of Low-Cycle Fatigue Curves of High-Strength and Welded Steel 10CrNi3MoV [PDF]

open access: yes, 2019
In this work is tested applicability of the extended uniform material law for high-strength steel on 10CrNi3MoV steel and its weld. Predicted low-cycle fatigue curves differ significantly from the measurements. Despite the reported scientific effort to
Kráčalík, Michal
core   +1 more source

SYHA1813, A VEGFR and CSF1R Inhibitor, in Patients With Recurrent High‐Grade Gliomas: A Multicenter, Open‐Label Phase I Study

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Recurrent high‐grade gliomas have a poor prognosis and limited therapeutic options. This study aimed to evaluate the safety and efficacy of SYHA1813, a dual inhibitor of VEGFR and CSF1R, in patients with recurrent high‐grade gliomas.
Zhuang Kang   +16 more
wiley   +1 more source

A fabrication history based strain-fatigue model for prediction of crack initiation in a radial loading wheel [PDF]

open access: yes, 2017
A strain-based fatigue model concerning fabrication history is applied to predict the fatigue life of a commercial car wheel under radial loads. As the prior conditions, the strain fatigue testing is performed on standard specimen of DP590 and FB540 ...
Gu, H.R   +7 more
core   +1 more source

FATIGUE AND ALCOHOL.* [PDF]

open access: yesBritish Journal of Inebriety, 1917
n ...
openaire   +2 more sources

Durability of Response to B‐Cell Maturation Antigen‐Directed mRNA Cell Therapy in Myasthenia Gravis

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective We report the 12‐month follow‐up outcomes from a Phase 2 clinical trial (NCT04146051) evaluating Descartes‐08, a BCMA‐directed RNA chimeric antigen receptor T‐cell (rCAR‐T) therapy for refractory generalized myasthenia gravis (MG).
Nizar Chahin   +10 more
wiley   +1 more source

Types of rotor failure and characteristics of fragments [PDF]

open access: yes, 1977
Noncontained rotor failures in U.K. engines resulting from low cycle fatigue, low cycle fatigue with superimposed high cycle fatigue, and overheating and-or overspeeding were analyzed.
Mccarthy, D.
core   +1 more source

Low cycle fatigue life improvement of AISI 304 by initial and intermittent wire brush hammering [PDF]

open access: yes, 2013
The effects of hammering by wire brush as a method of improving low cycle fatigue life of highly ductile austenitic stainless steel AISI 304 have been investigated through an experimental study combining imposed strain fatigue tests and assessment of ...
BRAHAM, Chedly   +4 more
core   +3 more sources

Home - About - Disclaimer - Privacy